PCVX to release OPUS-1 phase III data for VAX-31 by end-October
Vaxcyte said OPUS-1 phase III data for VAX-31 will target broader pneumococcal coverage and an improved immune response and is due for release by end of October.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results.
PCVX VAX-31 phase III data expected by end of October
OPUS-1 phase III data for VAX-31 are expected to be released by end of October. The company says commercial and manufacturing infrastructure is in place, with pediatric and Group A strep programs advancing.